Stock listing
NASDAQ:KITE Kite Pharma Inc Stock
Follow Kite Pharma Inc into a list and get an email when it puts out news.
Last close · NASDAQ:KITE
$179.79 USD
Close on Oct 3, 2017 · No longer trades
- Lowest – highest close
- $21.39 – $179.81 USDSince Jun 20, 2014 · lowest Jul 16, 2014 · highest Sep 29, 2017
Delisted NASDAQ:KITE no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:KITE
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Cynthia M. Butitta Other companies: Autolus Therapeutics plc (Chair of the Compensation Committee, Member of the Audit Committee · Since at least Mar 18, 2026); Century Therapeutics, Inc. (Director · Since at least Jun 17, 2021); Olema Pharmaceuticals, Inc. (Director · Since at least Aug 12, 2020); UroGen Pharma Ltd. (of the Audit Committee · Since at least Jan 1, 2019) | Chief Operating Officer · Jun 19, 2014 – Oct 3, 2017 · Past |
| Timothy L Moore Other companies: BioLife Solutions, Inc. (Director · Since at least Sep 1, 2022); Cerus Corporation (Director · Since at least Sep 5, 2018); Allogene Therapeutics, Inc. (Chief Technical Officer · Apr 24, 2023 – Feb 3, 2025 · Past); Instil Bio, Inc. (Chief Operating Officer · Sep 6, 2022 – Sep 6, 2022 · Past) | EVP, Technical Operations · Mar 15, 2016 – Oct 3, 2017 · Past |
| Jonathan M Peacock Other companies: Avantor, Inc. (Director · May 16, 2019 – May 8, 2025 · Past); Bellerophon Therapeutics Inc (Director · Feb 13, 2015 – Mar 31, 2021 · Past); Amgen Inc. (EVP & CFO · Apr 25, 2013 – Oct 28, 2013 · Past) | Director · Jun 19, 2014 – Oct 3, 2017 · Past |
| Jeffrey Wiezorek | SVP Clinical Development · Jul 15, 2015 – Oct 3, 2017 · Past |
| Paul L Jenkinson | Chief Financial Officer · May 16, 2016 – Oct 3, 2017 · Past |
Log in to ask 6ix AI your own questions about Kite Pharma Inc.